Whereas this chromosomal region has been reported to be lost in many cancers (18–21), suggesting a tumor-suppressor function for MPZL3, previously published bioinformatics data have suggested that MPZL3 is a prognostic marker in breast cancer (22). Here, MPZL3 is linked to breast carcinoma.